Big announcement on 3 March 2014:
Optiscan deploys its latest endomicroscope system for gastroenterology at St Vincent’s Hospital, Sydney.
Optiscan is pleased to announce the successful commencement of a clinical study being undertaken by gastroenterologists and scientists from the Garvan Institute of Medical research and St Vincent's Hospital (SydneyAustralia) in affiliation with the University of New South Wales (UNSW).
The study marks the introduction of Optiscan's second generation endomicroscopy platform into the field gastro enterology.
This market is now well established as a result of extensive use of Optiscan's previous generation platform via a product marketed by Pentax Medical Corporation
I don't recall any sales revenue in recent time so I expect this was a loan machine. Anyone know if the trial resulted in a paper?
Big announcement on 3 March 2014: Optiscan deploys its latest...
Add to My Watchlist
What is My Watchlist?
